hide You are viewing an archived web page, collected at the request of Publications Office of the European Union using Archive-It. This page was captured on 23:24:00 Aug 29, 2021, and is part of the European Union collection. The information on this web page may be out of date. See All versions of this archived page. Loading media information Skip to main content
Shaping Europe’s digital future logo
News article | Publication

Open Market Consultation: Next Generation Sequencing for Oncology

Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost and technology acceleration. 8 health procurers from 5 countries (BE, FR, DE, ES, IT) invite potentially interested bidders to participate in the online open market consultation meetings on 11-12 May 2021 in preparation of their upcoming oncNGS pre-commercial procurement. Aim of the procurement is to develop an affordable NGS tumor-marker analysis kit applicable to all tumor types that enables predictive, prognostic and diagnostic analysis in liquid biopsies.

The logo shows a drop of blood with the name of the project oncNGS under it